Abstract
Background
Hirschsprung disease (HSCR) is a congenital intestinal malformation. Previous HSCR animal model needs invasive operation on adult animal. The aim of this study is to establish an early-onset animal model which is consistent with the clinical manifestation of HSCR patients.
Methods
The neonatal mice were randomly divided into the benzalkonium chloride (BAC) group, treated with BAC via enema, and the control group, treated with saline. Weight changes, excretion time of carmine, CT scan, hematoxylin-eosin staining and immunofluorescence staining were used to evaluate the effect of the model. Differentially expressed genes (DEGs) in the HSCR mice were analyzed by using DAVID 6.8 database and compared with DEGs from HSCR patients.
Results
The weight of mice was lower and the excretion time of carmine was longer in the BAC group. Moreover, distal colon stenosis and proximal colon enlargement appeared in the BAC group. Neurons in the distal colon decreased significantly after 4 weeks of BAC treatment and almost disappeared completely after 12 weeks. Transcriptome profiling of the mouse model and HSCR patients is similar in terms of altered gene expression.
Conclusions
An economical and reliable HSCR animal model which has similar clinical characteristics to HSCR patients was successfully established.
Impact
-
The animal model of Hirschsprung disease was first established in BALB/c mice.
-
This model is an animal model of early-onset HSCR that is easy to operate and consistent with clinical manifestations.
-
Transcriptome profiling of the mouse model and HSCR patients is similar in terms of altered gene expression.
Similar content being viewed by others
Introduction
Hirschsprung disease (HSCR) is a congenital digestive system malformation which is mainly caused by abnormal migration and development of enteric neural crest cells (ENCCs) in the embryonic stage, resulting in the absence of ganglion cells of different lengths in the distal colon.1,2,3 The diseased bowel segment that lacks ganglia shows spastic stricture, causing abdominal distension and constipation.4 Clinically, HSCR patients usually develop vomiting, abdominal distension, constipation and other symptoms at the early stage of life and may be accompanied by serious complications, with a high mortality rate.5 The pathogenesis of HSCR remains unknown, and genetic and environmental factors are considered to be important influencing factors.6,7 Researchers are still committed to the study of the etiology, mechanism and treatment of HSCR.
Animal models are a critical tool for understanding the anatomy and pathophysiology of disease and exploring new treatments. Gene knockout mice are widely used in disease research, but the models based on single gene knockout have certain limitations in the study of complex polygenic diseases such as HSCR. Moreover, the single-gene knockout model is not suitable for the study of HSCR diseases caused by environmental factors. Besides, most knockout mice do not live long enough to meet the needs of experiments that focus on long-term outcomes.8 Therefore, a non-gene editing model with a good phenotype is in great demand. Since Sato et al.9 first reported that benzalkonium chloride (BAC) can cause the disappearance of intestinal ganglions in 1978, chemical induction animal models have received attention. As early as 2002, Yoneda et al.10 performed laparotomy using BAC on mice aged 12–16 weeks to establish an HSCR model. In 2014, Wagner et al.11 successfully established an animal model of HSCR in adult female Lewis rats by applying BAC to the descending colon through laparotomy. There are other models reported in adult mice with similar methods.12,13 So far, the chemical induction modeling approach is still dominated by invasive open surgery, and there is a lack of modeling in younger mice. Therefore, on the basis of previous research experience, we hope to explore an appropriate modeling method for neonatal mice to simulate the clinical characteristics of early-onset HSCR as much as possible and at the same time, to make an attempt in a simple and non-surgical way, so as to enrich the selection of HSCR animal models in future research.
In this study, an HSCR animal model with a simple method and early onset as a clinical manifestation of HSCR patients was established using neonatal BALB/c mice. During model establishment, BAC was applied to the colon via enema, which avoids the difficulty of surgical operation and reduces the mortality rate of animals. Besides, the selection of neonatal mice with immature intestinal nerve development fits the clinical feature of HSCR patients, which is beneficial to study the pathological mechanism of HSCR and evaluate new diagnosis and treatment methods.
Materials and methods
Experimental animals and protocols
Neonatal BALB/c mice at 5–8 days of age were selected [provided by Guangdong Yukang Biotechnology Co., Ltd., Production License: SCXK (Guangdong) 2020-0054] and randomly divided into the benzalkonium chloride (BAC) group (n = 12) and the control group (n = 12). All neonatal mice were breastfed by female adult mice, and adult mice were fed with mouse feed and water freely. All of them were kept in a specific pathogen-free environment (12 h light/12 h dark; temperature 25 ± 2 °C; humidity 55 ± 5%). All operations are in accordance with the regulations on the feeding and use of laboratory animals. This study was approved by the Animal Care and Use Committee of Guangzhou Women and Children Medical Center (NO. 2016042036).
Modeling approach
Enema tool preparation
Type 1: Select a number of 2 cm polytetrafluoroethylene (PTFE) tubes with outer diameters of 0.3, 0.5 and 0.6 mm, and insert them in turn from thin to thick according to the outer diameter. Then connect the 0.6 mm outer diameter end with no.6 needle, as shown in Supplementary Fig. 1A, and then use a 1 mL syringe for an enema.
Type 2: Type 1 enema tool without connecting 0.3 mm PTFE tubes, as shown in Supplementary Fig. 1B.
BAC treatment method
The neonatal mice were fixed with tape and connected to a syringe containing BAC (Sigma-Aldrich, St. Louis, MO, Batch Number: 12060) with the enema tool; the anterior segment was lubricated with paraffin oil and was finally inserted into the anus of the mice [Supplementary Fig. 1C]. In the BAC group, BAC treatment was performed at the first week of life (5–8 days of age, 4–5 g of weight in neonatal mice) and repeated in the second week (12–15 days of age, 6–10 g of weight) and in the third week (19–21 days of age, 8–12 g of weight) to induce colon neurons damage. In the first week and the second week, the type 1 tool was used, and the depth of the anal implantation was 0.5–1 cm and 1–1.5 cm, respectively. Then, 20 μL of 0.2% BAC solution would be injected twice in the first week and three times 20–40 μL of 0.2% BAC solution in the second week with a 10-min injection interval. In the third week, a type 2 enema tool was selected to be inserted through the anus at a depth of 1.5–2 cm, and four times 40–60 μL of 0.5% BAC solution were given with an interval of 10 min. In the control group, 0.9% saline (Kelun Pharmaceutical, China, Batch Number: AB8189) was used to replace BAC, while the rest processes were the same as the treatment group [Table 1 and Supplementary Fig. 2].
Model identification
Body weight change recording
The body weights of each animal were measured to understand the health status of mice.
Carmine lavage and red feces excretion
Carmine lavage experiment was conducted in the BAC group and the control group to evaluate the intestinal function: 4 weeks and 12 weeks after the BAC treatment, two groups of mice were alone cage, 1 mL carmine (Sigma-Aldrich, St. Louis, MO, Batch Number: SHBL4031) solution (6 mg/L) was used to perform lavage. At last, the time used for red feces excretion was calculated and compared.
Colography and micro-CT scanning
Three-dimensional reconstruction of colography of mice after micro-CT scanning reflected the intestinal lesions of mice: 12 weeks after the BAC treatment, the mice were anesthetized by intraperitoneal injection of 10 μL/g tribromoethanol (Nanjing Aibei Bio-Technology Co., LTD., China, Batch Number: 2039A). Later, 300–500 μL of 30% meglumine diatrizoate (Hanfeng, China, Batch Number: H20034058) would be used to highlight the intestine via enema. The mice were placed into micro-CT after waiting 2 min for better distribution of meglumine diatrizoate in the intestine.
Phenotype and histological analyses
Intestinal tissue samples were collected at 4 weeks and 12 weeks after the BAC treatment for phenotype identification. The tissue samples would then be fixed, embedded and sectioned. Immunofluorescence (IF) staining of protein gene product 9.5 (PGP9.5) polyclonal antibody (Abcam, Cambridge, MA, Batch Number: AB8189) and hematoxylin-eosin (H&E) staining were performed for detailed histologic examination.
Analysis and comparison of differentially expressed genes between the HSCR mouse model and human HSCR disease
RNA sequencing (RNA-seq)
Colon tissues of 12 weeks BAC-treated mice and control mice were extracted; similarly, ganglionic segment and aganglionic segment tissue samples from HSCR patients were also obtained. This study has been approved by the Ethics Committee of Guangzhou Women and Children’s Medical Center, and the written consent of the guardian of patients with HSCR has also been obtained. The total RNA of each sample was isolated and purified. RNA purity (OD260/280 and OD260/230 ratio) was detected by Nanodrop ND-1000 (Thermo Fisher Scientific, Waltham, MA), and RNA integrity was assessed by Agilent 4200 TapeStation (Agilent Technologies, Santa Clara, CA). LncRNA library was constructed by removing ribosomal RNA (rRNA). cDNA size in 200–300 bp was screened and purified PCR amplified library was obtained. The library was quantified using Qubit 2.0 Fluorometer (Thermo Fisher Scientific, Waltham, MA) and diluted to 1.5 ng/μL. The insert size was detected by Agilent 4200 TapeStation. The Illumina NovaSeq 6000 (Illumina, San Diego, CA) platform was used to generate PE150 NGS sequences.
RNA-seq bioinformatics
Raw FASTQ files were first quality controlled by removing joints, repeated sequences and low-quality sequences. Reference genomes and gene model annotation files (GRCh37 and GRCm38) were selected. HISAT2 (v2.1.0) was used for read mapping. The expression level of genes was obtained using the featureCounts software (v2.0.3). Differential genes among samples were analyzed using R package edgeR. A P-value less than 0.05 was treated as nominally significant. Finally, DAVID 6.8 database (https://david.ncifcrf.gov/) was used to conduct GO enrichment analysis.
Statistical analysis
Statistical analysis was performed using GraphPad Prism Software (v8.4.3). The numerical data were expressed as mean ± standard deviation (mean ± SD). Two-way ANOVA was used for the comparison of weight gain between the BAC treatment group and the control group, and Student’s t-test was used for the comparison of the remaining data between the two groups. A P-value less than 0.05 indicated that the difference was statistically significant.
Results
Survival analyses
A total of 24 neonatal mice were included in this study, and they were divided into the control group and the BAC group by random number method. In the control group, one mouse died after the first enema, and the other 11 mice survived. In the BAC group, one mouse died after the first enema, two mice died after the second enema, and nine mice survived.
BAC treatment affected weight gain suggesting the model’s disease status
The body weight of the BAC group mice increased slowly after the first BAC treatment, and the final body weight was significantly lower than that in the control group. The body weight change of mice is shown in Fig. 1.
BAC treatment resulted in prolonged excretion time, indicating intestinal peristalsis dysfunction
Carmine gavage test was performed in mice of two groups at 4 weeks and 12 weeks after the end of BAC treatment. The excretion time of carmine in the two groups can be used to evaluate the intestinal peristalsis function, thus reflecting the ablation status of intestinal neurons. Compared with the control group, mice in the BAC group showed slightly prolonged excretion time at 4 weeks (1.23 ± 0.29 h vs. 1.55 ± 0.27 h, P < 0.05), which indicated intestinal peristalsis dysfunction [Fig. 2a]; At 12 weeks, the intestinal peristalsis function of mice in the BAC group was severely impaired (1.47 ± 0.38 h vs. 4.26 ± 1.53 h, P < 0.01) [Fig. 2b].
Colography and micro-CT scan after BAC treatment showed megacolon formation
Three-dimensional reconstruction of colography of mice in this study was conducted after micro-CT scanning. Stenosis occurred in the distal colon of the BAC group, and a large amount of contrast agent accumulated in the intestinal lumen of the proximal colon, clearly indicating the local colon enlargement and irregular deformation [Fig. 3a], while the distal colon of the control group was uniform in thickness, and intestine enlargement was not observed [Fig. 3b].
Significant phenotype of megacolon was observed after 12 weeks of BAC treatment
The morphology of the colon in the 12th week after BAC treatment was observed. In the BAC group, fecal accumulation was obvious in the distal colon and the colon was obviously divided into dilated segment and narrow segment, forming an expanded colon with irregular shape and uneven thickness [Fig. 4a, b]. In contrast, the distal colon in the control group was uniform and smooth [Fig. 4c, d]. Besides, the length of the colon was found to be shorter in the BAC group than that in the control group (9.28 ± 0.25 cm vs. 11.20 ± 0.67 cm, P < 0.01) [Fig. 4e].
Histological analyses have proved the success of the HSCR modeling
HE and IF staining of colon tissue in the control group and the BAC group (4 weeks and 12 weeks after BAC treatment) were performed. Compared with the control group, the basic morphological structure of the mucosal layer, submucosal layer, musculature layer and serosal layer of intestinal tissue at 4 weeks and 12 weeks after BAC treatment were basically normal, but inflammatory cell infiltration was observed in the BAC group. IF staining of neurons with intestinal neuron-specific marker PGP9.5 showed that intestinal neurons in the control group were evenly distributed and abundant, and colon neurons in cross section were stained into perfect circular rings. However, the expression of PGP9.5 decreased significantly, and only a few neurons were scattered and unevenly distributed in the BAC group. Neuronal expression was undetectable in intestinal tissue in the BAC group after 12 weeks of BAC treatment, indicating the success of this approach in inducing an animal model of HSCR [Fig. 5].
Analysis and comparison of differentially expressed genes suggested the similarity between the HSCR mice and the HSCR patients
In this study, the colon tissues of three BAC mice and four control mice were collected for RNA sequencing. A total of 12,069 DEGs were detected by differential expression analysis, including many currently recognized HSCR-related genes [Fig. 6a]. In addition, a total of 10 patients with HSCR were recruited. The ganglionic segment and aganglionic segment tissue were collected for RNA sequencing, and 11,352 DEGs were found by differential expression analysis (Data unpublished). After comparison of DEGs between the two sets of data, we found 4210 overlapping DEGs [Fig. 6b]. GO enrichment analysis showed that DEGs in HSCR mice and HSCR patients were mainly enriched in items that were closely related to cell adhesion, cell proliferation and migration, nervous system development, and neuronal projection [Fig. 6c]. The results indicate that the transcriptome profiling of the mouse model and HSCR patients in this study reveals similar alterations in gene expression.
Discussion
HSCR is currently considered to be a developmental disorder of the enteric nervous system (ENS) due to disruption of ENCCs migration, proliferation, differentiation, survival, and/or apoptosis, resulting in a congenital lack of neurons in the intestinal tract.3,14,15 It is generally accepted that the ideal experimental model for studying human disease should simulate the disease in terms of anatomy, physiology and course. In this study, we established an HSCR animal model with simple operation, good phenotype, which replicates the etiology and the clinical symptoms of the human HSCR, including neurons in the distal colon decreased, poor weight growth, intestinal peristalsis dysfunction, distal colon stenosis and proximal colon enlargement, even biological information background.
Compared with gene knockout animal models, drug-induced animal models have the advantages of shorter modeling time and more economic benefits. BAC is a cationic surfactant that attaches to the cell membrane and causes its irreversible depolarization, which is more obvious on the cell membrane with a higher negative charge.10 Therefore, neurons in the intestine can be selectively destroyed.12,16,17 Sato et al.9 found that the application of BAC in the serosal layer of the colon also caused degeneration of other cells in the intestinal wall, but these lesions disappeared within a few weeks and the remaining tissues recovered completely except the intestinal wall neurons. So far, the mechanisms for the specificity of the neuron lesions after BAC exposure remain not well known. Sakata et al.18 suggested that this phenomenon might be related to the high sensitivity of intestinal neurons to BAC and the low resilience of neurons. Compared with the control group, except for the selective elimination of intestinal neurons, the basic morphological structures of the mucosal layer, submucosal layer, muscle layer and serosal layer in the BAC group were not damaged [Fig. 5]. To our knowledge, adult rats or mice are mainly selected in the current research on establishing the HSCR animal model by open surgery using BAC.10,11,12,19,20 However, adult rats or mice are not consistent with the clinical characteristics of HSCR patients, which manifests shortly after birth. In addition, surgical invasive procedures may lead to postoperative infection and intestinal adhesion, creating additional side effects and affecting phenotypic judgment. Besides, it has been reported that neurons can be detected again after nerve ablation in adult rats and mice using BAC.21,22,23 Studies have reported that nerve fibers regenerate and redominate muscles after BAC treatment. The regenerated neurons may come from peripheral neurons, submucosal nerve plexus or may be the result of migration and differentiation of neural progenitor cells in the transition region.22 However, after a single BAC treatment, the number of neurons regenerated in the previously aganglionic segment was much lower than in the control group.22 Theoretically, we selected neonatal mice with immature intestinal nerves24,25 for neuron ablation and repeated BAC treatment during modeling so that the intestinal neurons can be removed as far as possible.
In our modeling method, an enema of BAC solution was applied to reduce the impact of surgical treatment and improve the survival rate of the animals. In this study, it was found that, compared with the control group, the weight growth of mice in the BAC group was lower, which was consistent with the clinical symptoms of children with HSCR [Fig. 1]. Clinically, the weight growth of children with HSCR lags behind that of healthy children, and malnutrition is a common phenomenon in children with HSCR.22 Intestinal dyskinesia occurred in children with HSCR due to the loss of innervation of the colon and was later found to occur in BAC mice.26 The excretion time of carmine that evaluated the damage of intestinal peristalsis in mice was longer in the BAC group. Under our dynamic monitoring, with the progress of time, the excretion time in the BAC group became longer. This indicated that the damage to intestinal peristalsis function was gradually aggravated [Fig. 2]. In addition, the HCSR mice in our study had the typical intestinal phenotype consistent with children with HSCR, such as stenosis of the distal colon and swelling of the proximal colon with fecal accumulation.2 Immunofluorescence staining showed that colonic neurons were destroyed and disappeared in the BAC group [Fig. 5]. Therefore, we confirmed that the method successfully established the animal model of HSCR. Further, RNA-seq analysis of colonic tissues of the BAC group mice and HSCR patients showed that 4210 genes were co-enriched, and there were abundant co-enriched pathways [Fig. 6]. These findings indicate that the animal model established using BAC exhibits similar gene expression alterations to those observed in HSCR patients.
Taken together, we successfully established an experimental animal model of HSCR using BALB/c neonatal mice, enriching the existing animal models of HSCR and providing a reliable HSCR animal model for further research on its pathogenesis, treatment, clinical drug experiment, and so on.
Data availability
Data included in this manuscript are available upon request by contacting the corresponding author and will be freely available to any researcher wishing to use them for non-commercial purposes without breaching participant confidentiality.
References
Butler Tjaden, N. E. & Trainor, P. A. The developmental etiology and pathogenesis of Hirschsprung disease. Transl. Res. 162, 1–15 (2013).
Ambartsumyan, L., Smith, C. & Kapur, R. P. Diagnosis of Hirschsprung disease. Pediatr. Dev. Pathol. 23, 8–22 (2020).
Torroglosa, A. et al. Epigenetic mechanisms in Hirschsprung disease. Int. J. Mol. Sci. 20, 3123 (2019).
Klein, M. & Varga, I. Hirschsprung’s disease-recent understanding of embryonic aspects, etiopathogenesis and future treatment avenues. Medicina 56, 611 (2020).
Smith, C., Ambartsumyan, L. & Kapur, R. P. Surgery, surgical pathology, and postoperative management of patients with Hirschsprung disease. Pediatr. Dev. Pathol. 23, 23–39 (2020).
Karim, A., Tang, C. S. & Tam, P. K. The emerging genetic landscape of Hirschsprung disease and its potential clinical applications. Front. Pediatr. 9, 638093 (2021).
Fu, M. et al. Vitamin A facilitates enteric nervous system precursor migration by reducing Pten accumulation. Development 137, 631–640 (2010).
Chen, X. et al. Intestinal proinflammatory macrophages induce a phenotypic switch in interstitial cells of Cajal. J. Clin. Invest. 130, 6443–6456 (2020).
Sato, A. et al. Pathophysiology of aganglionic colon and anorectum: an experimental study on aganglionosis produced by a new method in the rat. J. Pediatr. Surg. 13, 399–435 (1978).
Yoneda, A., Shima, H., Nemeth, L., Oue, T. & Puri, P. Selective chemical ablation of the enteric plexus in mice. Pediatr. Surg. Int. 18, 234–237 (2002).
Wagner, J. P., Sullins, V. F., Khalil, H. A. & Dunn, J. C. A durable model of Hirschsprung’s colon. J. Pediatr. Surg. 49, 1804–1808 (2014).
Fujimura, T. et al. Fluorescence visualization of the enteric nervous network in a chemically induced aganglionosis model. PLoS ONE 11, e0150579 (2016).
Khalil, H. A. et al. Mouse model of endoscopically ablated enteric nervous system. J. Surg. Res. 200, 117–121 (2016).
Torroglosa, A. et al. Epigenetics in ENS development and Hirschsprung disease. Dev. Biol. 417, 209–216 (2016).
Ji, Y., Tam, P. K. & Tang, C. S. Roles of enteric neural stem cell niche and enteric nervous system development in Hirschsprung disease. Int. J. Mol. Sci. 22, 9659 (2021).
Levin, R. J. Actions of spermicidal and virucidal agents on electrogenic ion transfer across human vaginal epithelium in vitro. Pharm. Toxicol. 81, 219–225 (1997).
Garcia, S. B., Minto, S. B., Marques, I. S. & Kannen, V. Myenteric denervation of the gut with benzalkonium chloride: a review of forty years of an experimental model. Can. J. Gastroenterol. Hepatol. 2019, 3562492 (2019).
Sakata, K., Kunieda, T., Furuta, T. & Sato, A. Selective destruction of intestinal nervous elements by local application of benzalkonium solution in the rat. Experientia 35, 1611–1613 (1979).
Wagner, J. P., Sullins, V. F. & Dunn, J. C. A novel in vivo model of permanent intestinal aganglionosis. J. Surg. Res. 192, 27–33 (2014).
Zhang, N. N. et al. [Expression and function of T-Type Α1h Ca(2)(+) channels in the rat model of Hirschsprung disease]. Zhonghua Er Ke Za Zhi 54, 354–359 (2016).
Ramalho, F. S., Santos, G. C., Ramalho, L. N., Kajiwara, J. K. & Zucoloto, S. Myenteric neuron number after acute and chronic denervation of the proximal jejunum induced by benzalkonium chloride. Neurosci. Lett. 163, 74–76 (1993).
Hanani, M. et al. Regeneration of myenteric plexus in the mouse colon after experimental denervation with benzalkonium chloride. J. Comp. Neurol. 462, 315–327 (2003).
Yu, H., Pan, W., Wang, H. & Gao, Y. A time-limited and partially reversible model of hypoganglionosis induced by benzalkonium chloride treatment. Neurochem. Res. 41, 1138–1144 (2016).
Hagl, C. I. et al. The microenvironment in the Hirschsprung’s disease gut supports myenteric plexus growth. Int. J. Colorectal Dis. 27, 817–829 (2012).
de Vries, P., Soret, R., Suply, E., Heloury, Y. & Neunlist, M. Postnatal development of myenteric neurochemical phenotype and impact on neuromuscular transmission in the rat colon. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G539–G547 (2010).
Fox, D. A. & Bass, P. Pharmacological characterization of rat jejunal contractility after chronic ablation of the myenteric plexus. J. Pharm. Exp. Ther. 238, 372–377 (1986).
Acknowledgements
We thank Jiaojiao Xi and Jinglu Zhao for their technical advice and help.
Funding
H.X. is supported by the Science and Technology Planning Project of Guangdong Province (Grant NO. 2019B020227001). Y.Z. is supported by the grant of the National Natural Science Foundation of China (Grant NO. 81970450), the Science and Technology Project of Guangzhou (Grant NO. 201903010074) and the Guangdong Basic and Applied Basic Research Foundation (Grant NO. 2021A1515220146). Q.H. thanks the Medical Science and Technology Research Foundation of Guangdong Province of China (Grant NO. A2020076) and Guangzhou’s science and technology innovation and development special project (Grant NO. 202102080511). C.L. is supported by the China Postdoctor Science Foundation (Grant NO. 2023M730791) and the Research Foundation of Guangzhou Women and Children’s Medical Center for Clinical Doctor (Grant NO. 2023BS015). K.Y. is supported by the China Postdoctor Science Foundation (Grant NO. 2023M730793) and the Research Foundation of Guangzhou Women and Children’s Medical Center for Clinical Doctor (Grant NO. 2023BS014).
Author information
Authors and Affiliations
Contributions
C.L., Y.W., and Y.L. participated in analyzing data and wrote the manuscript. N.W., M.S., D.Q., W.Z., and X.Z., collected samples and information. Y.Z. and Q.H. revised the manuscript for important intellectual content. H.X. and Y.Z. coordinated the study over the entire time. All authors reviewed the final manuscript.
Corresponding authors
Ethics declarations
Competing interests
All authors declare no conflict of interest.
Ethics approval and consent to participate
In this study, procedures involving animals followed the ethical standards of the Helsinki Declaration as well as the institutional review board of Guangzhou Women and Children’s Medical Center (NO. 2016042036). Written consent has been obtained from the guardian of the patient with HSCR.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lan, C., Wu, Y., Liu, Y. et al. Establishment and identification of an animal model of Hirschsprung disease in suckling mice. Pediatr Res 94, 1935–1941 (2023). https://doi.org/10.1038/s41390-023-02728-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41390-023-02728-6